Key Metrics
Company Snapshot
Chai Discovery is a Biotech company, based in San Francisco, California, USA, founded 2024 by Joshua Meier, Matthew McPartlon, Jack Dent. Latest valuation $3.8B (As of Jul 31, 2026, Value Add Pulse research). Total funding $600M (As of Jul 31, 2026).
Recent changes
- Jul 31, 2026Jul 31, 2026First reported valuation: $3.8B Value Add Pulse enrichment
- Jul 31, 2026Jul 31, 2026First reported total funding: $600M Value Add Pulse enrichment
- Jul 17, 2026Jul 17, 2026Raised $400M Series C at a $3.8 billion valuation Crunchbase News
- Jul 17, 2026Jul 17, 2026New investor: Sequoia Capital Crunchbase News
- Jul 17, 2026Jul 17, 2026New investor: Dimension Crunchbase News
Earlier changes (3)
- Jul 17, 2026Jul 17, 2026New investor: Kleiner Perkins Crunchbase News
- Jul 17, 2026Jul 17, 2026New investor: Index Ventures Crunchbase News
- Jul 17, 2026Jul 17, 2026Chai Discovery Raises $400M at $3.8B for AI Drug Design Pulse story
Funding History
1 event · sources dated per row| Date | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Jul 17, 2026 | Series C | $400M | $3.8 billion | outlined = lead | Pulse story |
Investors
Latest Pulse
- Jul 21, 2026Dimension Capital Raises $800M Third Fund for Science-Compute BetsDimension Capital closed an $800 million third fund, 60% larger than its prior vehicle, betting on the intersection of biotech and AI compute after early wins including Chai Discovery's jump to a $3.8 billion valuation.→
- Jul 17, 2026Chai Discovery Raises $400M at $3.8B for AI Drug DesignLife-sciences AI startup Chai Discovery raised a $400 million Series C at a $3.8 billion valuation led by Index Ventures, Sequoia, Dimension and Kleiner Perkins, one of the largest rounds yet for AI-driven drug and molecule design.→
Coverage Timeline
newest firstAll Coverage
Dimension Capital Raises $800M Third Fund for Science-Compute Bets
Dimension Capital closed an $800 million third fund, 60% larger than its prior vehicle, betting on the intersection of biotech and AI compute after early wins including Chai Discovery's jump to a $3.8 billion valuation.
Chai Discovery Raises $400M at $3.8B for AI Drug Design
Chai Discovery Raises $400M at $3.8B for AI Drug Design
Life-sciences AI startup Chai Discovery raised a $400 million Series C at a $3.8 billion valuation led by Index Ventures, Sequoia, Dimension and Kleiner Perkins, one of the largest rounds yet for AI-driven drug and molecule design.
Value Add Research
Related Companies
Sources & methodologyshow
- Crunchbase Newsresearch database1 fact
- Value Add Pulse researchValue Add VC data2 facts
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.